Mediators of Inflammation / 2010 / Article / Tab 2 / Clinical Study
Circulating Cytokine Profiles and Their Relationships with Autoantibodies, Acute Phase Reactants, and Disease Activity in Patients with Rheumatoid Arthritis Table 2 Demographic, laboratory, and clinical data for the LDA (
𝑛
=
6
2
) and HDA (
𝑛
=
6
3
) groups of RA patients.
Parameters MDA HDA Quintiles Quintiles Mean ± SD Q1 (p25) Q2 (Median) Q3 (p75) Range Mean ± SD Q1 (p25) Q2 (Median) Q3 (p75) Range Age (years)
4
6
±
1
0
41 45 53 22–68
4
9
±
1
2
45 50 57 20–75 Female (%) 47 (75) 50 (80) Ethnicity: Black (%) 48 (78) 59 (94) DAS28-CRP
4
.
5
±
0
.
5
4.3 4.7 4.8 3.3–5.0
6
.
5
±
0
.
6
6.2 6.6 6.9 5.2–8.7 mHAQ-DI
3
.
3
±
1
.
7
2.0 3.6 4.5 0.0–6.0
1
.
8
±
0
.
8
1.3 2.1 2.4 0.0–3.0 Disease duration (months)
1
3
±
8
7 11 20 2–24
1
1
±
8
5 9 18 2–24 SJC
5
±
3
3 5 7 0–15
1
4
±
6
10 13 17 4–28 X-ray erosions (%) 28/53 (53) 29/57 (51) RF (IU/mL)
4
8
0
±
6
8
1
57 177 559 4–2860
4
9
1
±
8
1
2
21 178 654 10–5350 aCCP (U/mL)
6
1
8
±
6
3
9
51 343 1001 2–2026
7
3
4
±
6
6
7
89 599 1213 2–2527 aMCV (U/mL)
5
9
7
±
7
3
1
90 319 710 20–3028
6
3
8
±
7
2
7
108 334 868 16–3088 CRP (mg/L)
8
±
1
0
2 5 8 1–40
3
6
±
3
8
10 27 37 0–198 SAA (μ g/mL)
2
5
±
4
8
2 5 24 1–238
9
1
±
1
5
3
8 35 124 1–882
DAS28: Disease activity score for 28 joints, HDA: High disease activity, LDA: Low disease activity, mHAQ-DI: modified Health assessment questionnaire-disease Index, SJC: Swollen Joint Count, RF: Rheumatoid factor, aCCP: anticyclic citrullinated peptide antibodies, aMCV: Antimodified citrullinated vimentin antibodies, CRP: C-reactive protein, SAA: Serum amyloid A.
